Florence Healthcare closes $27M series C funding round
Clinical trial software company Florence Healthcare has completed its $27 million series C funding round, led by global software investor Insight Partners. Read More
Aizon unveils new data processing product
Aizon debuted its new good practice-compliant data processing product, Aizon Digitize, which supports life sciences manufacturers with digitization, productivity, and avoiding time-consuming data inputs. Read More
PerkinElmer debuts new automated GC-MS product
PerkinElmer launched its GC 2400 platform, an automated gas chromatography (GC) headspace sampler and GC-mass spectrometry (GC-MS) product. Read More
Researchers identify how bacterium that causes tuberculosis evolves rapidly
A new study has identified how the bacterium that causes tuberculosis can evolve rapidly in response to new environments, providing insights into how Mycobacterium tuberculosis grows to resist antibiotics with the potential for developing more effective treatments. Read More
Plant virus, antibody activates immune system's 'natural killer' cells
University of California, San Diego researchers have shown in a study that a new combination therapy to combat cancer may one day consist of a plant virus and antibody that activates the immune system's “natural killer” cells. Read More
Women in science get less credit for their contributions than men
Female scientists are less likely than their male counterparts to receive credit for their work on science research projects, according to a new study that for first time used a large set of data from universities showing exactly who was involved with the projects and got paid. Read More
Study shows breast cancer metastases form more efficiently during sleep
A new study by researchers at ETH Zurich, the University Hospital Basel, and the University of Basel shows that breast cancer metastases form more efficiently while patients are sleeping. Read More
Tuft cell discovery could lead to new way to treat deadly form of small cell lung cancer
Cold Spring Harbor Laboratory researchers have discovered how tuft cells are generated in the body, offering hope that disrupting tuft cell development could lead to a new way to treat this deadly type of small cell lung cancer. Read More
Molecular 'zipper' causes degeneration of the eye’s photoreceptors
A research team from the University of Geneva, in collaboration with the University of Lausanne, has discovered that the absence of a molecular “zipper” formed by four proteins leads to cell death in retinal cells. The discovery of the essential role played by the zipper could lead to the development of therapeutic approaches for retinitis pigmentosa, a degenerative genetic eye disease. Read More
Scientists discover novel mechanism by which neurons, glia collaborate
Champalimaud Foundation scientists have discovered a novel mechanism by which neurons and glia collaborate to drive neural regeneration following brain injury. Their findings may help develop drugs to promote the formation of new neurons following brain damage. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter